Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Orange Grove Bio
AddedFeb 15, 2024
UpdatedJun 28, 2026
Orange Grove Bio

Orange Grove Bio

Seed

OGB: A preclinical biotech platform advancing affordable drug discovery and clinical trials.

HQ
Cincinnati, OH, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Orange Grove Bio (OGB) is a preclinical drug investment and development platform founded with the mission to reduce the cost of drug discovery and accelerate the advancement of therapies into clinical trials. The company focuses on transformative therapies for cancer, autoimmune, and inflammatory diseases, leveraging partnerships with universities to drive innovation. OGB aims to improve patient quality of life by expediting the development of new medical breakthroughs.

Notable affiliated individuals include experts in therapeutic development and cancer research. The company has achieved significant milestones in reducing drug discovery costs and advancing promising therapies towards clinical trials. Through its strategic university collaborations, OGB has made a substantial impact on the biotech industry, fostering the rapid development of treatments for critical diseases.

Orange Grove Bio - Similar Companies

Grove Biopharma logo

Grove Biopharma

grovebiopharma.com

Orchid BioVentures logo

Orchid BioVentures

Orionis Biosciences logo

Orionis Biosciences

orionisbio.com

Greenstone Biosciences logo

Greenstone Biosciences

Orchid logo

Orchid

orchidhealth.com

Orca Pharmaceuticals logo

Orca Pharmaceuticals

Ochre Bio logo

Ochre Bio

ochre-bio.com

Orphinic Scientific logo

Orphinic Scientific

orphinic.com

Groove Biopharma logo

Groove Biopharma

Orion BioScience logo

Orion BioScience

Ordaos logo

Ordaos

ordaos.bio

Curie.Bio logo

Curie.Bio

curie.bio

Asalyxa Bio logo

Asalyxa Bio

Ora Biomedical logo

Ora Biomedical

orabiomedical.com

GRO Biosciences logo

GRO Biosciences

grobio.com

Orange Grove Bio - Quick Facts

Who are Orange Grove Bio's competitors?

Companies similar to Orange Grove Bio include Grove Biopharma, Orchid BioVentures, Orionis Biosciences and Greenstone Biosciences.

When was Orange Grove Bio founded?

Orange Grove Bio was founded in 2019.

Where is Orange Grove Bio's headquarters located?

Orange Grove Bio's headquarters is located in Cincinnati, OH, US.

When was Orange Grove Bio's last funding round?

Orange Grove Bio's most recent funding round was for $2M (USD) in September 2023.

How much has Orange Grove Bio raised to-date?

As of Sep 28, 2023, Orange Grove Bio has raised a total of $18.6M (USD).

How many employees does Orange Grove Bio have?

Orange Grove Bio has 35 employees as of Feb 5, 2024.

Orange Grove Bio - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Platform
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research